-
-
-
-
-
-
-
60 Degrees Pharmaceuticals (SXTP) Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
70,925 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

